Annual report pursuant to Section 13 and 15(d)

Condensed Statement of Cash Flows

v3.22.0.1
Condensed Statement of Cash Flows
 5 Months Ended
Dec. 31, 2020
USD ($)
Cash Flows from Operating Activities:  
Net loss $ (7,117,234)
Adjustments to reconcile net loss to net cash used in operating activities:  
Interest earned on investments held in Trust Account (82)
Loss on sale of private placement warrants 2,871,152
Warrant issuance costs 1,138,086
Unrealized gain on change in fair value of warrant liability 2,948,911
Changes in current assets and current liabilities:  
Prepaid assets (634,512)
Due to related party 2,885
Accounts payable 137,179
Net cash used in operating activities (653,615)
Cash Flows from Investing Activities:  
Investment held in Trust Account (300,000,000)
Net cash used in investing activities (300,000,000)
Cash Flows from Financing Activities:  
Proceeds from Initial Public Offering, net of underwriters' fees 294,000,000
Proceeds from private placement 8,000,000
Advances from Sponsor 634,447
Proceeds from issuance of promissory note related party 275,000
Proceeds from (Repayments of) Related Party Debt (275,000)
Repayment of advances from Sponsor (634,447)
Payment of offering costs (607,056)
Net cash provided by financing activities 301,417,944
Net Change in Cash 764,329
Cash—Beginning 0
Cash—Ending 764,329
Supplemental disclosure of noncash financing activities  
Year-end value of Class A common stock subject to possible redemption 300,000,000
Initial classification of warrant liability 27,987,400
Deferred underwriting commissions charged to additional paid-in capital 10,500,000
Founder Shares [Member]  
Cash Flows from Financing Activities:  
Proceeds from issuance of found shares $ 25,000